
PARENT SESSION1:45 PM to 3:30 PM Sunday, April 21, 2002 NAHS Mini-Symposium 3 NAHS Thermochemotherapy Room: Nevada 1-2 Chair: Bull, Joan226431 Fannin St., Medical Onc MSB 5.280, Houston, TX, Co-Chair: Park, John33Box 1710, San Francisco, CA Speakers: Repasky, Elizabeth4; Goldberg, S. Nahum5; Poulson, Jean6; Park, John7; Bull, Joan84Elm & Carlton Streets, Buffalo, NY5330 Brookline Ave., Boston, MA6Box 3455, Durham, NC7Box 1710, San Francisco, CA86431 Fannin St., Medical Onc MSB 5.280, Houson, TX (MS03-) Thermochemotherapy. (MS03-1) Mild (fever-range) whole body hyperthermia can selectively increase tumor vascular volume and vessel permeability and can increase the delivery and anti-tumor effectiveness of DOXIL (liposome encapsulated doxorubicin). (MS03-2) Radiofrequency Tumor Ablation Combined with Liposomal Doxorubicin. (MS03-3) Thermosensitive liposomal doxorubicin combined with local hyperthermia in dogs with spontaneous tumors. (MS03-4) Hyperthermia Significantly Enhances Drug Delivery and Efficacy of Pegylated Liposomal Doxorubicin in Metastatic Breast Cancer of the Chest Wall: A Phase I/II Study . (MS03-5) A Phase I-II clinical trial of fever-range whole-body hyperthermia combined with liposomal doxorubicin (Doxil), 5-fluorouracil (5FU), & metronomic interferon- |